|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9753 USD | -0.90% |
|
-4.38% | -29.33% |
Health-care companies fell amid concerns about earnings season.
An experimental Johnson & Johnson vaccine failed to protect against HIV infection compared with a placebo, among men and transgender people in a clinical trial.
Shares of J&J fell to their lowest level since November.
Bluebird Bio stock fell sharply after the biotech concern unveiled a planned secondary offering of 20 million shares.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
01-18-23 1703ET
| 1st Jan change | Capi. | |
|---|---|---|
| -29.33% | 190M | |
| +15.82% | 121B | |
| +20.35% | 113B | |
| +17.47% | 26.02B | |
| -25.31% | 19.39B | |
| -19.51% | 15.91B | |
| -19.67% | 15.09B | |
| -46.87% | 15.06B | |
| +62.55% | 14.93B | |
| +6.34% | 13.85B |
BLUEBIRD BIO, INC. 
